Discover how generic drugs and biosimilars saved the US healthcare system $3.4 trillion over a decade and why they are critical for keeping prescription costs manageable.
Patent litigation in the generic drug market is delaying affordable medicines by years. Learn how the Hatch-Waxman Act, Orange Book abuses, and serial lawsuits are blocking competition-and what’s being done to fix it.